Doripenem description: Difference between revisions
No edit summary |
No edit summary |
||
| Line 17: | Line 17: | ||
|- | |- | ||
|}<ref>{{Cite web | last = |first = |title = http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022106s014lbl.pdf |url =http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022106s014lbl.pdf | |}<ref>{{Cite web | last = |first = |title = http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022106s014lbl.pdf |url =http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022106s014lbl.pdf | ||
publisher = |date = | accessdate = }}</ref> | publisher = |date = | accessdate = }}</ref> | ||
==References== | ==References== | ||
Revision as of 01:50, 26 December 2013
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Description
DORIBAX®, doripenem monohydrate for injection vials contain 500 mg of doripenem on an anhydrous basis, a white to slightly-yellowish off-white sterile crystalline powder. All references to doripenem activity are expressed in terms of the active doripenem moiety. The powder is constituted for intravenous infusion. The pH of the infusion solution is between 4.5 and 5.5.
DORIBAX® is not formulated with any inactive ingredients.
DORIBAX® (doripenem monohydrate) is a synthetic broad-spectrum carbapenem antibiotic structurally related to beta-lactam antibiotics. The chemical name for doripenem monohydrate is (4R,5S,6S)-3-[((3S,5S)-5-[[(aminosulfonyl)amino]methyl]-3-pyrrolidinyl)thio]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid monohydrate.
Its molecular weight is 438.52, and its chemical structure is:
 |
References
- ↑ [http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022106s014lbl.pdf
publisher = "http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022106s014lbl.pdf"] Check
|url=value (help). line feed character in|url=at position 75 (help); External link in|title=(help)
Adapted from the FDA Package Insert.